Screener
Summit Therapeutics SMMT Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Summit Therapeutics’s 10-K, filed February 23, 2026.
- Filed
- Feb 23, 2026, 4:10 PM EST
- Fiscal year
- FY2025
- Accession
- 0001599298-26-000015
FAQ
- What is Summit Therapeutics's operating lease liabilities (total)?
- Summit Therapeutics (SMMT) reported operating lease liabilities (total) of $20.89M in Q4 2025.
- How has Summit Therapeutics's operating lease liabilities (total) changed year-over-year?
- Summit Therapeutics's operating lease liabilities (total) increased by 189.4% year-over-year, from $7.22M to $20.89M.
- What is the long-term trend for Summit Therapeutics's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Summit Therapeutics's operating lease liabilities (total) has grown at a 114.0% compound annual growth rate (CAGR), from $465K to $20.89M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Summit Therapeutics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude